Search results for #Stock
Un trader profesional no intenta predecir el futuro; más bien, identifica escenarios probables y los explota al máximo. Mi habilidad en el trading mejoró significativamente cuando comencé a interpretar las señales del mercado en lugar de intentar predecir su dirección #Stock
#Stock : Close$ | Change$ | WoW | MoM | YoY $UVXY: 33.27 | $1.33 | -1.31% | 5.12% | -82.35% 2024-04-30
May 1 #SPX500 #Sector #Stock Top Movements Another End Of Day Selloff The biggest declines 📉were via #Earnings $CVS $SBUX $SWKS $NCLH $EL $JCI $GNRC $KHC $CLX etc Some of winners via Earnings $GRMN $AMCR $DD $VRSK $PFE $EXR etc $XLU #Utilities were again Green
#Stock : Close$ | Change$ | WoW | MoM | YoY $DRV: 45.42 | $2.55 | 2.67% | 19.24% | -6.35% 2024-04-30
#Stock : Close$ | Change$ | WoW | MoM | YoY $MCD: 273.04 | $-0.51 | -1.39% | -2.0% | -6.14% 2024-04-30
To all traders : What’s up with these guys hitting you up and asking you if the market is treating you good and if you’re taking profits? Sounds like doing recon for a scam if you ask me. #trading #stock #Crypto #ScamAlert
#Stock : Close$ | Change$ | WoW | MoM | YoY $HUBS: 604.87 | $-31.29 | -7.2% | -3.96% | 45.84% 2024-04-30
Key Development: Iovance ($IOVA 🚀Stock Price: $12.5) Advances in PHASE3 Clinical Trial! New Frontiers in Metastatic Melanoma Treatment. Click for More: clinicaltrials.gov/study/NCT05727… #stockintelligence #tradingpsychology #stock
Revolutionizing Trading with a Social Twist! Traderverse - where AI-powered tools and community insights meet. Invest in innovation at WeFunder and be part of the future. Visit : wefunder.com/traderverse #socialtrading #fintech #Trading #Stock #Crypto #Stockmarket
MetLife Beats on Profit, Approves $3 Billion Share Buyback $MET #AInvest #AInvest_Wire #USstock #tradeideas #stock View more: ftn.ai/T17G6LIF6
#Dividends/#Interest made in April 2024: Checking Account: $0.00 Savings Account: $0.01 Credit Union Account: $0.62 #Stock Portfolio: $106.90 #IRA: $33.46
#Stock : Close$ | Change$ | WoW | MoM | YoY $WMT: 59.35 | $-0.89 | 0.44% | -2.01% | 18.82% 2024-04-30
Key Development: Cabaletta Bio ($CABA 🚀Stock Price: $12.41) Advances in PHASE2 Clinical Trial! New Frontiers in Systemic Lupus Erythematosus Treatment. Click for More: clinicaltrials.gov/study/NCT06121… #stock #USstock #stocksInNews
#SMARTPHONES #NEWS - Realme 12 Pro+, P1 Pro, Narzo 70, Buds Air 5, a kensbookinfo.blogspot.com/p/infotech.htm… #SOUTHAMERICA - Brazil registers over244thousand formaljobs inM kensbookinfo.blogspot.com/p/etc-continen… #STOCK #MARKET #NEWS - US DEA proposes significant shift in marijuana kensbookinfo.blogspot.com/p/markets.html…